文献速递衰弱、肌少症与跌倒老年慢病共病管理

预测老年房颤患者非维生素K拮抗剂口服抗凝药处方的因素

Identifying Factors That Predict the Prescription of Non-vitamin K Antagonist Oral Anticoagulants in Older Individuals With Atrial Fibrillation.
PubMed 文献 · J Am Med Dir Assoc · 2019-03-08

该研究回顾了加拿大安大略省25家长期护理机构2015年5月的电子病历与药房数据,纳入273名≥65岁房颤抗凝患者。

要点

  • 在长期护理机构房颤抗凝患者中,CHESS评分≥2与NOACs处方几率增加2.46倍独立相关。
  • 未发现其他患者层面因素与NOACs处方独立相关。

核心结论

  • 在长期护理机构接受口服抗凝治疗的房颤患者中,较高的CHESS评分(≥2)与相比华法林更倾向使用NOACs相关。

研究设计与样本

  • 回顾性队列研究,回顾加拿大安大略省25家长期护理机构2015年5月的电子病历和药房数据,纳入273名≥65岁房颤抗凝患者。

主要发现

  • 273名房颤抗凝患者中,159名(58%)使用NOACs,114名(42%)使用华法林。
  • 未发现其他患者层面因素与NOACs处方相关。

关键数值与推荐

  • CHESS评分≥2作为衰弱的替代标志。

临床怎么用

  • 在长期护理机构房颤患者中,衰弱程度较高(CHESS≥2)可能促使医生更倾向选择NOACs而非华法林。
  • 高血压患者选择NOACs的趋势需进一步研究验证。

局限性

  • 研究为回顾性设计,仅纳入长期护理机构人群,结果外推需谨慎。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Factors that influence decision of non-vitamin K antagonist oral anticoagulants (NOACs) use among older atrial fibrillation (AF) patients in long-term care (LTC) facilities have not been well studied. The aim of this study was to assess whether increased frailty influenced physicians to prescribe NOACs over warfarin. DESIGN: We retrospectively reviewed the electronic medical record (EMR) and pharmacy data of 25 LTC facilities in Ontario, Canada, in May 2015. The diagnosis of AF was ascertained from EMR and confirmed by complete chart review of a random sample of the cohort. A score of ≥2 on the Changes in Health, End-stage disease, Signs, and Symptoms (CHESS) scale was used as a surrogate marker of frailty. MEASURES: Multivariable logistic regression model was used to assess whether a higher frailty score is associated with the use of NOACs in comparison to warfarin, independent of potential patient-level confounders. SETTING AND PARTICIPANTS: In total, 3378 active residents were assessed in 25 LTC facilities. All the residents were ≥65 years old. We identified 433 residents with AF; 273 (63%) AF residents were on anticoagulation therapy and included in the analysis. RESULTS: Residents were more often treated with NOACs (n = 159; 58%) in comparison to warfarin (n = 114; 42%). A CHESS score of ≥2 increased the odds of prescribing NOACs by 2.46 times [95% confidence interval (CI) 1.11, 5.49; P = .03] when adjusted for important patient-level factors. Patients with hypertension had a trend of increased NOAC prescriptions but did not reach statistical significance [odds ratio 2.1 (95% CI 0.91, 4.81), P = .08]. None of the patient-level factors were associated with NOAC prescriptions. CONCLUSIONS AND IMPLICATIONS: In this real world cohort of AF patients in LTC who are prescribed an oral anticoagulation therapy, a higher CHESS score (≥2) is associated with increased use of NOACs in comparison to warfarin.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Shurrab M, Ko DT, McElhaney J, et al. Identifying Factors That Predict the Prescription of Non-vitamin K Antagonist Oral Anticoagulants in Older Individuals With Atrial Fibrillation. J Am Med Dir Assoc. 2019. PMID: 30853427. doi:10.1016/j.jamda.2019.01.131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。